Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Novel palladium-catalyzed bis-carbonylation route offers high yields and substrate compatibility for scalable pharmaceutical intermediate manufacturing.
Patent CN115286609B details a novel ruthenium-catalyzed route ensuring high purity and safety. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed aminocarbonylation route for quinolin-2(1H)-ones using benzisoxazole. High yields, simple operation, cost-effective manufacturing for pharmaceutical intermediates.
Patent CN112480015A details a novel one-pot Pd-catalyzed method for synthesizing 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost and efficiency advantages.
Patent CN110294708B details a metal-free synthesis of trifluoroethylselenophenanthridine derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel green electrochemical route for 6-7-5 fused ring sulfonamides. Metal-free, mild conditions, scalable for high-purity pharmaceutical intermediates manufacturing.
Patent CN115215810B reveals catalyst-free synthesis for high-purity pharmaceutical intermediates ensuring cost reduction and supply chain reliability for global buyers.
Patent CN112250614B details a metal-free, one-pot synthesis of 3-spiro-tricyclic indolones using NBS, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN108033866B details a green Ru-catalyzed cyclization for naphthalene derivatives, offering cost reduction in optoelectronic material manufacturing and high-purity pharmaceutical intermediates.
Patent CN107641068A reveals a palladium-catalyzed route for indanone derivatives offering significant supply chain stability and reduced environmental waste for manufacturers.
Patent CN113354573A reveals a scalable route for alpha,alpha-terpyridine. Eliminate palladium residues and achieve 99.4% purity for optical and pharma applications.
Patent CN112939780A details a Rh-catalyzed C-H activation route for indanone derivatives, offering high yields and functional group tolerance for reliable pharmaceutical intermediate supply.
Patent CN113735777B reveals a metal-free route for cyclic thiourea compounds. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN115353511A details a safe, multi-component Pd-catalyzed carbonylation route for indolinone-imidazole derivatives, offering significant supply chain advantages.
Patent CN111606808A reveals a mild Suzuki coupling method for Fluxapyroxad intermediates, offering high purity and scalable production capabilities.
Patent CN112778352B details a novel Pd-catalyzed ortho-C-H silylation method. This route offers high atom economy and streamlined supply chains for pharmaceutical intermediates.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles disclosed in CN110467579B. Cost-effective, scalable route for API intermediates without heavy metals.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Offers cost-effective, scalable routes for API intermediates without heavy metals.
Novel room-temperature synthesis of trifluoromethyl 1,2,4-triazines via sulfur ylide cycloaddition. Offers cost reduction in API manufacturing and scalable production.